In-Vitro Toxicity Testing Market is Dazzling Worldwide and Forecast to 20301
In-vitro toxicity testing market is anticipated to grow at a significant CAGR during the forecast period. In vitro is the process that helps examine harmful chemicals over the isolated part of the organism. It is used to identify hazardous chemical substances and helps detect the toxicity at the early stages of the development of new products such as drugs, cosmetics, and food additives. The in vitro toxicity testing is mainly used for safety evaluation in drug development and also for ranking the chemicals according to their potency. The absorption, distribution, metabolism, excretion (ADME), dose-response, threshold response of the drug can also be determined by the in vitro toxicity testing.
The major factors that are
expected to accelerate the market growth during the forecast period include an
increase in awareness about the environmental concerns and an increase in the
number of R&D procedures, which require in vitro testing, ban on animal
testing. Moreover, advancements in genetics and genetic screening approaches
and the emergence of new approaches of 3D cell culture are also anticipated to
boost the global in-vitro toxicity testing market during the forecast period.
The global in-vitro toxicity testing market
analysis includes some of the key market players such as Agilent Technologies,
Inc., BioReliance, Inc., Alere, Inc., Charles River Laboratories International,
Inc., and General Electric Company, among others. To maintain a strong position
in the market, these market players are adopting various strategic moves, such
as product launches, partnerships, collaborations, and mergers and
acquisitions. For instance, In August 2019, Covance launched a laboratory solution
within its functional service provider (FSPx) offering, comprising a clinical
analytics service and clinical operations capabilities.
To Request a Sample of our Report on In-Vitro
Toxicity Testing Market: https://www.omrglobal.com/request-sample/in-vitro-toxicity-testing-market
Market Coverage
·
The market number available for – 2023-2030
·
Base year- 2023
·
Forecast period- 2024-2031
·
Segment Covered
·
Regions Covered- Globally
Competitive Landscape: Agilent Technologies, Inc., BioReliance, Inc.,
Alere, Inc., Charles River Laboratories International, Inc., and General
Electric Company, among others.
In-Vitro Toxicity Testing Market by Segment
By Product & Service
•
Consumables
•
Assay
•
Equipment
•
Software
•
Services
By Toxicity Endpoints
• ADME
• Skin Irritation
• Corrosion
• Other
By Industry
• Pharmaceutical
• Cosmetics
• Food
• Others
A
full Report of In-Vitro Toxicity Testing Market is Available @ https://www.omrglobal.com/industry-reports/in-vitro-toxicity-testing-market
In-Vitro Toxicity Testing Market by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/in-vitro-toxicity-testing-market
About Orion Market Research
Orion Market Research (OMR) is a market research and
consulting company known for its crisp and concise reports. The company is
equipped with an experienced team of analysts and consultants. OMR offers
quality syndicated research reports, customized research reports, consulting
and other research-based services. The company also offer Digital Marketing
services through its
subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment